Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A

Clinical trial NCT01029340 · COMPLETED

Trial details

NCT number: NCT01029340
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Blood Coagulation Disorders Hemophilia A

Start date: 2009-12-01
Primary completion: 2012-06-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.